M. Borges (Lisbon, Portugal), M. Pesek (Plzen, Czech Republic)
The evaluation of the ventilatory function in the pulmonary resections for the boncho-pulmonary cancer
N. Galie, C. Marica, C. Roiu ()
|  |
Complications following pneumonectomy in patients with lung cancer and associated cardiopulmonary pathology
P. K. Yablonsky, O. B. Ilyina, I. M. Kuznetsov, A. R. Kozak, V. G. Pischik (St-Petersburg, Russia)
| |
Possibilities of predicting cardiorespiratory complications in patients underwent pneumonectomy for non small-cell lung cancer (NSCLC)
O. B. Ilyina, E. S. Oganesova, L. D. Kiryukhina, I. M. Kuznetsov, P. K. Yablonsky (St-Petersburg, Russia)
| |
Results of surgical treatment in elderly patients with non-small cell lung cancer (NSCLC)
E. Jassem, W. Rzyman, R. Dziadziuszko, W. Zurek, A. Szymanowska, J. Skokowski, J. Jassem (Gdañsk, Poland)
| |
Our operated lung cancer cases and their survival results
N. Koseoglu, E. S[idot]l[idot]strel[idot], O. İt[idot]l, U. Acikel, A. Akkoclu, A. Kargi, R. Cetingoz, U. Yilmazu, E. Osma, B. Degirmenci (Izmir, Turkey)
| |
Endoscopical laser treatment in combined therapy non small cell lung cancer (NSCLC)
M. K. Mistulova, S. V. Orlov, V. A. Gerasin, T. V. Bigday (St.-Petersburg, Russia)
| |
The role of radiotherapy (RTH) in long-term survival limited disease (LD) small cell lung cancer (SCLC) patients (pts) treated in the National TB and Lung Diseases Research Institute
P. Remiszewski, K. Roszkowski-Sliz, B. Roszkowska-Sliz, E. Wiatr, J. Zych, E. Rowinska-Zakrzewska (Warsaw, Poland)
| |
Induction chemotherapy (IC) followed by surgery (S) for advanced non-small cell lung cancer (NSCLC)
M. Donghi, P. Antonelli, R. Giura (Como, Italy)
| |
Early concurrent chemoradiotherapy for limited small cell lung cancer (LSCLC). Analysis of toxicity and survival of 30 consecutive patients
Z. Skacel, M. Marel, B. Malinova, J. Prausova, K. Kosatova (Prague, Czech Republic)
| |
A retrospective study of lung parenchymal damage after neoadjuvant chemo and radiotherapy for non small cell lung cancer
T. Oggionni, C. Nascimbene, P. Morbini, C. Bassi, G. Orlandoni, A. Baio, S. Inghilleri, A. Cascina, A. Rossi, U. Magrini (Pavia, Italy)
| |
Treatment of advanced and metastatic non small cell lung carcinoma (NSCLC) with a new schedule of gemcitabine (GEM) plus cisplatin (CDDP)
A. Marin, V. Palmisano, D. Errante, A. Bianco, L. Salvagno, S. Nardini (Vittorio Veneto, Italy)
| |
The comparison of paclitaxel-carboplatin (PCp) versus gemcitabine-cisplatin (GC) in the treatment of locally advanced or metastatic non-small cell lung cancer
M. Yaman, S. Erturan, G. Aydin, A. N. Annakkaya, S. Cömert, E. Duman, I. Talasli (Istanbul, Turkey)
| |
Gemcitabine and cisplatin ( GD) as first line chemotherapy in patients with non-small-cell lung cancer (NSCLC)
M. Borges, E. Teixeira, R. Sotto-Mayor, A. Bugalho de Almeida (Lisboa, Portugal)
| |
Docetaxel and carboplatin as the second-line treatment of non-small cell lung cancer
V. Hola, M. Pesek (Plzen, Czech Republic)
| |
Biologically-targeted therapy of NSCLC-our first experience with ZD 1839
M. Pesck, B. Eliasova (Plzen, Czech Republic)
| |
Pegylated liposomal doxorubicin compared with traditional doxorubicin in combination chemo-radiotherapy for small cell lung cancer
P. Giamboudakis, N. Georgatou, K. Marosis, H. Lambrakis, D. Nikolakakou, A. Papacharalambous ()
| |
Chemotherapy for lung cancer in Scotland: a national survey
R. Milroy, T. S. Ismail, J. McPhelim, S. Davidson, R. Bradley, R. Jones (Glasgow, United Kingdom)
| |
Are home visits by a specialist lung cancer nurse worthwhile?
A. Bain, R. Rabbini, M. B. Allen (Stoke-on-Trent, United Kingdom)
| |